moxonidine has been researched along with Age-Related Memory Disorders in 2 studies
moxonidine: structure given in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sub-acute brain ischemia is a risk factor for the development of vascular dementia (VaD)." | 1.40 | Pharmacological modulation of I(1)-imidazoline and α2-adrenoceptors in sub acute brain ischemia induced vascular dementia. ( Gupta, S; Sharma, B, 2014) |
| "Treatment with moxonidine, NDDCT and TBZ significantly attenuated 3-NPA induced reduction in body weight, locomotor activity, grip strength, anxiety as well as impaired learning and memory." | 1.40 | Pharmacological benefit of I(1)-imidazoline receptors activation and nuclear factor kappa-B (NF-κB) modulation in experimental Huntington's disease. ( Gupta, S; Sharma, B, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gupta, S | 2 |
| Sharma, B | 2 |
2 other studies available for moxonidine and Age-Related Memory Disorders
| Article | Year |
|---|---|
Pharmacological modulation of I(1)-imidazoline and α2-adrenoceptors in sub acute brain ischemia induced vascular dementia.
Topics: Acetylcholinesterase; Adrenergic alpha-2 Receptor Agonists; Animals; Brain; Brain Ischemia; Catalase | 2014 |
Pharmacological benefit of I(1)-imidazoline receptors activation and nuclear factor kappa-B (NF-κB) modulation in experimental Huntington's disease.
Topics: Adrenergic Uptake Inhibitors; Animals; Anxiety; Brain; Disease Models, Animal; Ditiocarb; Huntington | 2014 |